VIDEO: 4: Intersection of HIV, HCV, & Substance Use Disorder (1/27/21)
This virtual event is the fourth and last session in the series entitled "Intersecting Epidemics in the Context of Ending the Epidemic: Tackling HIV, Substance Use, and HCV". This series is co-sponsored by the MidAtlantic AIDS Education and Training Center (MAAETC), the National Alliance for HIV Education and Workforce Development (NAHEWD), the Opioid Response Network (ORN), the Mid-Atlantic Regional Public Health Training Center, and the Central East Addiction Technology Transfer Center (ATTC).
Session title: Intersection of HIV, Hep C, and Substance Use Disorders: Challenges and Opportunities of Integration
Audience: health care providers and staff working at HIV clinics, infectious disease clinics, substance use disorder treatment programs, opioid treatment programs and others
- Discuss the intersection of hepatitis C infection and substance use disorders
- Describe two challenges and opportunities of integrating HIV, hepatitis C, and substance use disorder prevention and treatment into a healthcare setting
- Identify four benefits of Medication-Assisted Treatment (MAT)
- Identify two challenges and two opportunities for linking MAT clients to HIV, hepatitis B, and hepatitis C care after screening
A variety of the listed populations will be discussed at this event.
- Other special populations
A variety of the listed topics will be discussed at this event.
- Harm Reduction/Safe Injection
- HIV Transmission Risk Assessment
- Antiretroviral treatment adherence, including viral load suppression
- HIV diagnosis (i.e. HIV testing)
- Linkage to Care
- Hepatitis C
- Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
- Substance use disorders
- Opioid use disorder